BRIEF published on 05/20/2026 at 17:50, 5 months 9 days ago Mauna Kea Technologies is expanding into the Middle East Mauna Kea Technologies CellTolerance Middle East Expansion Regulatory Authorizations Irritable Bowel Syndrome
BRIEF published on 05/20/2026 at 17:50, 5 months 9 days ago Mauna Kea Technologies s'étend au Moyen-Orient Mauna Kea Technologies Autorisations Réglementaires CellTolerance Expansion Moyen-Orient Syndrome De L'intestin Irritable
PRESS RELEASE published on 05/20/2026 at 17:45, 5 months 9 days ago Informations privilégiées / Autres communiqués Mauna Kea Technologies obtient des autorisations réglementaires aux Émirats Arabes Unis et en Turquie pour CellTolerance. Expansion commerciale dans une région avec forte prévalence du syndrome de l'intestin irritable Expansion Commerciale Mauna Kea Technologies Autorisations Réglementaires CellTolerance Syndrome Intestin Irritable
BRIEF published on 05/18/2026 at 17:50, 5 months 11 days ago Mauna Kea Technologies Proposes New Board Members Annual General Meeting Shareholder Voting Strategic Transformation Board Nominations Mauna Kea Technologies
BRIEF published on 05/18/2026 at 17:50, 5 months 11 days ago Mauna Kea Technologies propose de nouveaux membres au conseil d'administration Assemblée Générale Annuelle Transformation Stratégique Vote Des Actionnaires Nominations Au Conseil D'administration Mauna Kea Technologies
PRESS RELEASE published on 05/18/2026 at 17:45, 5 months 11 days ago Inside Information / Other news releases Mauna Kea Technologies nominates 3 new directors to accelerate strategic transformation in 2025. Shareholder approval awaited for upcoming Annual General Meeting Annual General Meeting Shareholder Approval New Directors Strategic Transformation Mauna Kea Technologies
BRIEF published on 04/15/2026 at 17:50, 6 months 14 days ago Mauna Kea Technologies en forte croissance au T1 2026 Chiffre D'affaires Croissance Cellvizio Technologies Médicales Intolérances Alimentaires
BRIEF published on 04/15/2026 at 17:50, 6 months 14 days ago Mauna Kea Technologies to experience strong growth in Q1 2026 Revenue Growth Medical Technologies Cellvizio Food Intolerances
PRESS RELEASE published on 04/15/2026 at 17:45, 6 months 14 days ago Informations privilégiées / Autres communiqués Mauna Kea Technologies annonce une forte croissance de ses ventes au T1 2026, avec des ventes totales en hausse de +68% à taux de change constant (TCC) et +57% en publié Croissance Ventes Mauna Kea Technologies CellTolerance T1 2026
BRIEF published on 03/11/2026 at 17:50, 7 months 18 days ago Mauna Kea Technologies Achieves Milestone with CLIMB Study Mauna Kea Technologies Cellvizio Pancreatic Cysts CLIMB Study ASGE Plenary Session
Published on 10/29/2026 at 22:01, 11 hours 4 minutes ago Pinetree Capital Announces Unaudited Financial Results for the Period Ended September 30, 2026
Published on 10/29/2026 at 21:30, 11 hours 35 minutes ago Shelfie Announces Amendments to Previously Announced Acquisition of Aspect
Published on 10/29/2026 at 18:30, 14 hours 35 minutes ago Kidoz Inc. Appoints Derek Sentner as Chief Revenue Officer
Published on 10/29/2026 at 16:05, 17 hours ago SouthGobi Announces Date of Special Meeting of Shareholders and The Record Date
Published on 10/30/2026 at 08:50, 14 minutes ago EQS-Adhoc: Evonik Industries AG: Statement by the Executive Board of Evonik Industries AG, October 30, 2026
Published on 10/30/2026 at 08:05, 59 minutes ago ANTHBOT N Series Robot Mower Named to TIME's List of the Best Inventions of 2026
Published on 10/30/2026 at 08:00, 1 hour 5 minutes ago NatWest Markets Q3 26 Interim Management Statement
Published on 10/30/2026 at 08:00, 1 hour 5 minutes ago PUMA Q3 2026 sales performance improves sequentially – FY 2026 outlook updated
Published on 10/30/2026 at 08:00, 1 hour 5 minutes ago Neoen secures AUD 1.8 billion in debt financing to support renewable energy portfolio in Australia
Published on 10/30/2026 at 07:00, 2 hours 5 minutes ago Groupe DLSI - Chiffre d'affaires 3ème trimestre 2026
